Comparison of Traditional Treatments and Therapeutic Vaccines for Breast Cancer
DOI:
https://doi.org/10.54097/3m9zjy95Keywords:
Therapeutic vaccine; breast cancer; immunotherapy.Abstract
One prevalent malignant tumor that poses a major risk to women's health is breast cancer. In addition, breast cancer is also one of the main causes of female mortality. Despite this, most breast cancer still uses traditional treatment, including surgery, chemotherapy, radiotherapy, etc. Although traditional treatment can control the disease process, there are a series of problems and limitations. Thus, there is an urgent need for novel therapies to improve the prognosis and the standard of living for those with breast cancer. Immunotherapy, as an innovative method of treatment, is receiving increasing attention. Cancer immunotherapy works by using the immune system's defenses to stop cancer from spreading and eradicate cancerous cells. Therapeutic vaccines are a highly anticipated immunotherapy. The unique advantages of therapeutic vaccines may become one of the main directions for cancer treatment. However, there are still many problems and challenges with cancer therapeutic vaccines at present. This review aims to discuss the advantages and research progress of therapeutic vaccines for breast cancer and discuss the potential and challenges of vaccines in the treatment of breast cancer. It aims to provide reference and guidance for further research on therapeutic vaccines against breast cancer.
Downloads
References
Barzaman K, Karami J, Zarei Z, et al. Breast cancer: Biology, biomarkers, and treatments. International immunopharmacology, 2020, 84: 106535.
Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. The British Journal of Radiology, 2022, 95(1130): 20211033.
Waks A G, Winer E P. Breast cancer treatment: a review. Jama, 2019, 321(3): 288-300.
Swain S M, Shastry M, Hamilton E. Targeting HER2-positive breast cancer: Advances and future directions. Nature Reviews Drug Discovery, 2023, 22(2): 101-26.
Morse M A, Gwin Iii W R, Mitchell D A. Vaccine therapies for cancer: then and now. Targeted oncology, 2021, 16(2): 121-52.
Behranvand N, Nasri F, Zolfaghari Emameh R, et al. Chemotherapy: A double-edged sword in cancer treatment. Cancer immunology, immunotherapy, 2022, 71(3): 507-26.
Saxena M, Van Der Burg S H, Melief C J, et al. Therapeutic cancer vaccines. Nature Reviews Cancer, 2021, 21(6): 360-78.
Igarashi Y, Sasada T. Cancer vaccines: toward the next breakthrough in cancer immunotherapy. Journal of Immunology Research, 2020, 2020.
Sobhani N, Scaggiante B, Morris R, et al. Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treatment Reviews, 2022, 109: 102429.
Hargrave A, Mustafa A S, Hanif A, et al. Recent advances in cancer immunotherapy with a focus on FDA-approved vaccines and Neoantigen-based vaccines. Vaccines, 2023, 11(11): 1633.
Zhang T, Jou T H-T, Hsin J, et al. Talimogene Laherparepvec (T-VEC): A Review of the Recent Advances in Cancer Therapy. Journal of Clinical Medicine, 2023, 12(3): 1098.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







